Abiopharma

New Form 8-K - Aptose Biosciences Inc. Filed: 2025-06-20 AccNo: 0001171843-25-003985 Size: 193 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Emergent BioSolutions Announces Addition to Russell3000® Index

New Form S-8 - RAPT Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143245 Size: 618 KB

New Form 8-K - Blueprint Medicines Corp Filed: 2025-06-20 AccNo: 0001558370-25-008742 Size: 176 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 11-K - HENRY SCHEIN INC Filed: 2025-06-20 AccNo: 0001000228-25-000036 Size: 280 KB

New Form 8-K - Acurx Pharmaceuticals, Inc. Filed: 2025-06-20 AccNo: 0001104659-25-060902 Size: 660 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Semler Scientific, Inc. Filed: 2025-06-20 AccNo: 0001104659-25-060899 Size: 194 KB Item 8.01: Other Events

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

New Form 8-K - Hoth Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001213900-25-055834 Size: 203 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form DEF 14A - NanoVibronix, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015735 Size: 1 MB

BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar

PETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry

ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry